Manisha C Balwani MD
Clinical Genetics
Associate Professor, Genetics & Genomic Sciences, Icahn School of Medicine
Join to View Full Profile
1184 Fifth Avenue2ND floorNew York, NY 10029
Phone+1 212-241-0915
Fax+1 212-426-9065
Dr. Balwani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Medical Genetics and Genomics, 2003 - 2006
Zucker School of Medicine at Hofstra/Northwell at Forest Hills HospitalResidency, Internal Medicine, 2000 - 2003
Topiwala National Medical CollegeClass of 1997
Certifications & Licensure
NY State Medical License 2006 - 2027
American Board of Medical Genetics and Genomics Clinical Genetics
Clinical Trials
- Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact Start of enrollment: 2012 Jul 01
- Oral Iron for Erythropoietic Protoporphyrias Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- Self-Reported Liver Disease and the Burden of Erythropoietic Protoporphyria.Hetanshi Naik, Kristen Wheeden, Hilary H Colwell, Susan D Mathias, Chelsea Norregaard
JIMD Reports. 2025-05-01 - 1 citationsLiver involvement in a large cohort of patients with erythropoietic protoporphyria or X-linked protoporphyria.Cynthia Levy, Hetanshi Naik, Jessica Overbey, Karli Hedstrom, Kelly Wang
Hepatology Communications. 2025-03-01 - 2 citationsCase-based discussion of the acute hepatic porphyrias: Updates on pathogenesis, diagnosis and management.Manisha Balwani, Siobán Keel, Peter Meissner, Mark Sonderup, Penelope Stein
Liver International. 2025-03-01
Press Mentions
New Four-Year, $3.26 Million Grant from the National Institute of Neurological Disorders and Stroke Establishes the Mount Sinai Center for Undiagnosed DiseasesSeptember 17th, 2024- Dersimelagon Increases Duration of Symptom-Free Sunlight Exposure in Erythropoietic Protoporphyria: NEJMApril 20th, 2023
- Dersimelagon Beneficial for Erythropoietic, X-linked ProtoporphyriaApril 13th, 2023
- Join now to see all
Other Languages
- Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
